![]() ![]() "Provider understanding of the 2013 ACC/AHA cholesterol guideline". Virani S.S., Pokharel Y., Steinberg L., et al. "Factors associated with clinical inertia: an integrative review". Aujoulat I., Jacquemin P., Rietzschel E., et al. "Use of lipid-lowering therapies over 2 years in GOULD, a registry of patients with atherosclerotic cardiovascular disease in the US". Cannon C.P., de Lemos J.A., Rosenson R.S., et al. "Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review". De Vera M.A., Bhole V., Burns L.C., Lacaille D. "Lipid testing and statin dosing after acute myocardial infarction". Wang W.T., Hellkamp A., Doll J.A., et al. "Association of clinician knowledge and statin beliefs with statin therapy use and lipid levels (a survey of US practice in the PALM registry)". "Beliefs, risk perceptions, and lipid management among patients with and without diabetes: results from the PALM registry". Lowenstern A., Li S., Virani S.S., et al. "Does clinician-reported lipid guideline adoption translate to guideline-adherent care? An evaluation of the Patient and Provider Assessment of Lipid Management (PALM) registry". "Patient-reported reasons for declining or discontinuing statin therapy: insights from the PALM registry". "ACC/AHA special report: clinical practice guideline implementation strategies: a summary of systematic reviews by the NHLBI implementation science work group: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". Chan W.V., Pearson T.A., Bennett G.C., et al. "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". Grundy S.M., Stone N.J., Bailey A.L., et al. "Assessment of trends in statin therapy for secondary prevention of atherosclerotic cardiovascular disease in US adults from 2007 to 2016". Yao X., Shah N.D., Gersh B.J., Lopez-Jimenez F., Noseworthy P.A. "National trends in statin use and expenditures in the US adult population from 2002 to 2013: insights from the medical expenditure panel survey". Salami J.A., Warraich H., Valero-Elizondo J., et al. "Association between intensity of statin therapy and mortality in patients with atherosclerotic cardiovascular disease". Rodriguez F., Maron D.J., Knowles J.W., Virani S.S., Lin S., Heidenreich P.A. "Adoption of the 2013 American College of Cardiology/American Heart Association cholesterol management guideline in cardiology practices nationwide". "Trends in high-intensity statin use and low-density lipoprotein cholesterol control among patients enrolled in a clinical pharmacy cardiac risk service". Lamprecht D.G., Shaw P.B., King J.B., Hogan K.N., Olson K.L. "Antihyperlipidemic medication treatment patterns and statin adherence among patients with ASCVD in a managed care plan after release of the 2013 ACC/AHA guideline on the treatment of blood cholesterol". ![]() Bellows B.K., Olsen C.J., Voelker J., Wander C. "Temporal changes in statin prescription and intensity at discharge and impact on outcomes in patients with newly diagnosed atherosclerotic cardiovascular disease-real-world experience within a large integrated health care system: the IMPRES study". Anderson J.L., Knowlton K.U., May H.T., et al. "2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". Stone N.J., Robinson J.G., Lichtenstein A.H., et al. "Intensive lipid lowering with atorvastatin in patients with stable coronary disease". LaRosa J.C., Grundy S.M., Waters D.D., et al. "Intensive versus moderate lipid lowering with statins after acute coronary syndromes". Cannon C.P., Braunwald E., McCabe C.H., et al. "Interpretation of the evidence for the efficacy and safety of statin therapy". Collins R., Reith C., Emberson J., et al. Eur Heart J Qual Care Clin Outcomes 2019 5:225-232. ![]() "Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register data". "Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age". Lloyd-Jones D.M., Leip E.P., Larson M.G., et al. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |